Pre-earnings options volume in Maravai LifeSciences (MRVI) is 4.3x normal with calls leading puts 36:1. Implied volatility suggests the market is anticipating a move near 16.5%, or 0c, after results are released. Median move over the past eight quarters is 12.1%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVI:
- May 05, 2025 Deadline: Contact Levi & Korsinsky LLP to Join Class Action Suit Against MRVI
- Hold Rating on Maravai Lifesciences Due to Filing Delays and Financial Reporting Concerns
- Maravai LifeSciences Delays 2024 Annual Report Filing
- Maravai Lifesciences price target lowered to $8 from $9 at BofA
- Biotech Alert: Searches spiking for these stocks today